Xiaoli Qin

Xiaoli Qin


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 March 2025 in Foods
Verified
Journal Article
Open access
PDF file
XZXiaoqin Zhang
Xiaoqin Zhang
WZWei Zhou
Wei Zhou
XQXiaoli Qin
Xiaoli Qin
chunsheng houchunsheng hou
chunsheng hou
Xiushi YangXiushi Yang
Xiushi Yang
Hemp is a multiuse crop used for fiber, food, and medicinal purposes. The seed of hemp has attracted great attention as a good plant protein resource with remarkable nutritional and biological properties. However, the application of hemp seed protein (HSP) is limited due to its unsatisfactory functional properties. Physical, chemical, and biological technologies have been explored to modify the structure of HSP and improve its functionality. The investigation of the biological activity of HSP and its derived peptide to deal with intestinal, metabolic, and muscle concerns has broadened its utilization in healthy products. Therefore, the current review is performed to summarize the recent research progress on the novel extraction and modification of HSP, as well as the purification and identification of active peptide. The multi-functional multi-bioactive properties and adverse effects of HSP and peptide are also depicted to facilitate their potential applications in the food industry.

16 October 2025 in Life
Verified
Journal Article
Open access
PDF file
JTJialing Tang
Jialing Tang
XLXi Li
Xi Li
DXDa Xu
Da Xu
GLGenggui Liu
Genggui Liu
XZXiaoqin Zhang
Xiaoqin Zhang
Xiushi YangXiushi Yang
Xiushi Yang
Bast fibrous plants are recognized as potential sources of pectin, yet the structural characteristics and functional properties of pectic polysaccharides derived from these plants remain insufficiently investigated. In this study, three pectic polysaccharides (HP, KP, and RP) were isolated from the bast fibers of Cannabis sativa L. (hemp), Hibiscus cannabinus L. (kenaf), and Boehmeria nivea L. (ramie) using an ammonium oxalate solution. Their chemical composition, monosaccharide profile, molecular weight, microstructure, and functional groups were analyzed by spectroscopic and chromatographic techniques. These polysaccharides exhibited remarkable uronic acid content (50.49–61.14%), a relatively low degree of esterification (19.51–34.26%), and high molecular weights ranging from 147.10 to 242.16 kDa. The predominant neutral sugars identified were rhamnose, arabinose, and galactose. Furthermore, HP, KP, and RP demonstrated superior thermal stability, emulsifying properties, water/oil holding capacity, and cholesterol binding ability compared with commercial citrus pectin (CP). They also exhibited stronger radical scavenging activity, with KP showing particularly notable antioxidant performance (IC50 = 1856 and 1485 μg/mL for the DPPH and ABTS assays, respectively). Overall, these findings indicate that bast fibrous plants are promising alternative sources of pectic polysaccharides with favorable antioxidant properties, supporting their potential application as food additives or functional ingredients.

15 August 2025 in Foods
Verified
Journal Article
Open access
PDF file
XQXiaoli Qin
Xiaoli Qin
XYXiai Yang
Xiai Yang
yanchun Dengyanchun Deng
yanchun Deng
litao Guolitao Guo
litao Guo
ZLZhimin Li
Zhimin Li
chunsheng houchunsheng hou
chunsheng hou
Lower respiratory infections predominantly affect children under five and the elderly, with influenza viruses and respiratory syncytial viruses (including SARS-CoV-2) being the most common pathogens. The COVID-19 pandemic has posed significant global public health challenges. While vaccination remains crucial, its efficacy is limited, highlighting the need for complementary approaches to mitigate immune hyperactivation in severe COVID-19 cases. Medicinal plants like Cannabis sativa show therapeutic potential, with over 85% of SARS-CoV-2-infected patients in China receiving traditional herbal treatments. This review explores the antiviral applications of cannabis and its bioactive compounds, particularly against SARS-CoV-2, while evaluating their pharmacological and food industry potential. Cannabis contains over 100 cannabinoids, terpenes, flavonoids, and fatty acids. Cannabinoids may block viral entry, modulate immune responses (e.g., suppressing pro-inflammatory cytokines via CB2/PPARγ activation), and alleviate COVID-19-related psychological stress. There are several challenges with pharmacological and food applications of cannabinoids, including clinical validation of cannabinoids for COVID-19 treatment and optimizing cannabinoid solubility/bioavailability for functional foods. However, rising demand for health-focused products presents market opportunities. Genetic engineering to enhance cannabinoid yields and integrated pharmacological studies are needed to unlock cannabis’s full potential in drug discovery and nutraceuticals. Cannabis-derived compounds hold promise for antiviral therapies and functional ingredients, though further research is essential to ensure safety and efficacy.